期刊文献+

葡萄糖苯氮芥衍生物的合成及抗肿瘤活性的研究

Study of synthesis and anti-tumor activities of the benzene nitrogen mustard glucoside derivate
下载PDF
导出
摘要 目的探讨新合成的葡萄糖苯氮芥衍生物对肝癌7721细胞的生长抑制及其诱导凋亡的作用。方法采用MTT,流式细胞术分析法。结果新合成的葡萄糖苯氮芥衍生物对正常细胞毒性较小,对7721有明显的细胞毒性,且通过流式细胞仪显示其诱导细胞凋亡。结论新合成的葡萄糖苯氮芥衍生物能明显抑制肝癌细胞的生长,诱导细胞凋亡是其抗肿瘤作用的主要机制之一。 Objective To analyze the new synthesis benzene nitrogen mustard glucoside derivate inhibit the growth and induce the apoptosis of 7721 hepatumor cells. Methods The experiments were used by MTr and FCM. Results The new synthesis benzene nitrogen mustard glucoside derivate is much lower toxicity to normal cellsd and much higher toxicity to 7721 cells 'compared with nitrogen mustard, meanwhile it induce the apoptosis of 7721 cells by the FCM. Conclusion The new synthesis benzene nitrogen mustard glucoside derivate can inhibit the growth of 7721 hepatumor ceils and induce the apoptosis which is the one of the main mechanisms of antiturnour.
出处 《中国实验诊断学》 2007年第8期1011-1013,共3页 Chinese Journal of Laboratory Diagnosis
基金 本课题受吉林省科技厅基金资助(20020801)(20030708)
关键词 靶向性治疗 氮芥 葡萄糖苯氮芥衍生物 肝癌7721细胞 targeted therapy nitrogen mustard benzene nitrogen mustard glucoside derivate 7721 hepatoeellular carcinoma
  • 相关文献

参考文献4

二级参考文献46

  • 1陈婷梅,祝彼得.抗白血病中药及天然药物的研究现状[J].中国中西医结合杂志,1995,15(5):317-320. 被引量:56
  • 2[1]Mark P, Dennis S. Biological rationale for HER2/neu as a target for monoclonal antibody therapy[J]. Seminars in Oncology, 2000, 27(5, Suppl 9): 13-19.
  • 3[2]Ravdin PM, Chamness GC. The cerbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular marker-a review[J]. Gene, 1995, 159:19.
  • 4[3]Fornier M, Esteva FJ, Seidman AD, et al. Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer[J]. Semin Oncol, 2000, 27(6 Suppl 11): 38- 45.
  • 5[4]Christiane JB, Wenbiao L, Darren WD, et al. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases[J]. Cancer, 2000, 89: 488- 499.
  • 6[5]Paul P, Takashi M, Keiji I, et al. Anti-epidermal growth gactor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice[J]. Clinical Cancer Research, 1999, 5: 257-264.
  • 7[6]Carol M R, Sally J, DeNardo. Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies[J]. Critical Reviews in Oncology/Hematology, 2001, 38: 25-35.
  • 8[7]Bagshawe KD. Antibody directed enzymes revive anti-cancer prodrug concept[J]. Br J Cancer, 1987, 56: 531-532.
  • 9[8]Konstantions NS, Agamemnon AE. Antibody directed prodrug therapy(ADEPT): A review of the experimental and clinical consideration[J]. Cancer Res, 1999, 19: 605-614.
  • 10[9]Huwyler J, Yang J, Pardridge WM, et al. Receptor mediated delivery odaunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat[J]. J Pharmacol Exp Ther, 1997, 282: 1541-1546.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部